N6-Methyladenosine (m6A), the most abundant internal modification of eukaryotic mRNA, is dynamically reversed by the FeII/α-ketoglutarate-dependent dioxygenase ALKBH5, a key m6A “eraser” that regulates target mRNA fate through demethylation. ALKBH5 is aberrantly overexpressed in acute myeloid leukemia, glioblastoma, br...
Chen Deng, Hai Xu, Jian Pu et al.· Frontiers in Pharmacology· 0 citations
This study elucidates a therapeutically targetable KPNB1-p65-Bcl-2 survival axis in multiple cancers and establishes a foundation for developing next-generation KPNB1 inhibitors.
Cong Li, Qiaohua Yan, Muhammad Muddasar Saeed et al.· Cell Chemical Biology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.